Form 8-K - Current report:
SEC Accession No. 0001437749-22-004328
Filing Date
2022-02-24
Accepted
2022-02-24 16:14:54
Documents
14
Period of Report
2022-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20220221_8k.htm   iXBRL 8-K 30455
2 EXHIBIT 99.1 ex_339250.htm EX-99.1 102143
  Complete submission text file 0001437749-22-004328.txt   277688

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20220224.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20220224_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20220224_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20220224_pre.xml EX-101.PRE 11688
8 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20220221_8k_htm.xml XML 2576
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 22671114
SIC: 2836 Biological Products, (No Diagnostic Substances)